TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
ELTX

Elicio Therapeutics Inc.

Healthcare · Biotechnology

1.90$ +0.5% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ELTX
Line item 2012 2013 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
18.7% 23.7% 96.4% 51.4% 85.2% 94.5% 47.3% 60.2% 73.4% 74.7%
12.7% 18.6% 95.8% 46.9% 73.1% 92.0% 34.4% 47.5% 62.5% 71.8%
12.7% 18.6% 95.8% 46.9% 73.1% 92.0% 34.4% 47.5% 62.5% 71.8%
5.3% 4.4% 0.4% 3.7% 10.6% 0.8% – – – –
– 0.0% – -0.5% -9.8% 0.2% 18.6% – – –
– – – 12.0% 2.2% 0.9% 37.5% – – –
61.6% 59.7% 29.0% 256.4% 291.0% 15.5% 60.7% 58.1% 140.1% 93.7%
10.0% 10.4% 27.6% 223.6% 226.9% 11.7% 30.3% 35.9% 40.9% 31.4%
1.0% 1.1% – 57.9% 170.1% 1.0% 3.1% 3.4% 3.2% 3.9%
1.9% 0.3% 2.0% 94.6% 11.8% 4.9% 12.4% 16.1% 3.7% 2.6%
– – – – – – – – 71.1% 36.4%
15.5% 21.2% 71.0% -156.4% -191.0% 84.5% 39.3% 41.9% -40.1% 6.3%
15.5% 21.1% -149.5% -676.9% -339.1% -222.9% -472.1% -523.8% -688.8% -903.5%
0.1% 0.1% 11.1% 68.6% 17.2% 3.3% 13.7% 18.6% 43.3% 59.2%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?